2024-518407-22-00
Active, not recruiting
Phase 4
Clinical Trial To Determine The Efficacy And Safety Of Insulin Eye Drops In Dry Eye In Patients With Topical Hypotensors
Hospital Clinico San Carlos, Hospital Clinico San Carlos1 site in 1 country100 target enrollmentStarted: October 16, 2024Last updated:
Overview
- Phase
- Phase 4
- Status
- Active, not recruiting
- Sponsor
- Hospital Clinico San Carlos, Hospital Clinico San Carlos
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Changes in dry eye symptoms from baseline to 6 months after treatment time
Overview
Brief Summary
The goal of this clinical trial is to evaluate the preliminary efficacy of the use of insulin eye drops in the control of dry eye disease in patients with topical hypotensors, compared to placebo (artificial tears).
Eligibility Criteria
- Ages
- 18 years to 65+ years (65+ Years, 18-64 Years)
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients who provide written informed consent and who are able and willing to comply with all scheduled study visits and procedures.
- •Patients ≥ 18 years at the screening visit.
- •Ocular hypertension or glaucoma controlled with hypotensive treatment
- •Diagnosis of dry eye
Exclusion Criteria
- •Uncontrolled glaucoma with expected changes in antihypertensive treatment in the next 6 months
- •Patients with a history of allergy or hypersensitivity to the study medication or any of its excipients
- •Modifications in systemic immunosuppressive treatment in the last 6 months
- •History of alcohol or drug abuse
- •Patients who have received an experimental drug or used an experimental medical device in the 30-day period prior to the screening visit.
- •Systemic pathology (cardiopulmonary pathology, connective tissue disorders, neurological or psychiatric pathology) or situation of the patient that does not allow examination (such as mental or psychomotor retardation).
- •Any other disease or condition that, at the discretion of the investigator, could constitute a risk to the participant or interfere with the results of the study.
- •Changes in topical glaucoma treatment in the last 3 months
- •Severe dry eye requiring immediate treatment
- •Previous eye surgery, except cataract surgery more than 12 months ago
Outcomes
Primary Outcomes
Changes in dry eye symptoms from baseline to 6 months after treatment time
Changes in dry eye symptoms from baseline to 6 months after treatment time
Secondary Outcomes
- Change of corneal staining from baseline to 6 months after treatment
- Change in corneal aesthesiometry from baseline to 6 months after treatment
- Change in conjunctival hyperemia from baseline to 6 months after treatment
- Change in non-invasive tear film break-up time from baseline to 6 months after treatment
- Change in light dispersion from baseline to 6 months after treatment
- Change in cytokine levels from baseline to 6 months after treatment
- Changes in therapeutic compliance with hypotensive treatment
- Proportion of patients presenting adverse effects
Investigators
Barbara Burgos Blasco
Scientific
Hospital Clinico San Carlos
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 3
Multicenter, controlled, randomized, observer-blinded clinical trial to evaluate the efficacy and safety of insulin eye drops (1 IU/ml) in the treatment of persistent corneal epithelial defect.2024-518818-53-00Hospital Clinico San Carlos234
Not yet recruiting
Not Applicable
Safety and Efficacy of Kelulut Honey Eyedrops in Dry Eye DiseaseNCT07279324Universiti Sains Malaysia45
Recruiting
Not Applicable
Kelulut Honey for Allergic Conjunctivitis and Dry Eye SymptomsNCT07273747Universiti Sains Malaysia72
Recruiting
Phase 4
Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical HypotensorsDry EyeGlaucomaNCT06017362Barbara Burgos Blasco100
Recruiting
Phase 4
Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.NCT06939959Khyber Teaching Hospital126